Well, Miebo is about to be the #1 drug in Dry Eye. Beating Xiidra already and Restasis in many markets. Sorry you are a Hater.Fentanyl has a better drug profile.
I hate alcon, but they have the number one drug in dry eye. It's called Systane. Sorry, you're drug is junk.Well, Miebo is about to be the #1 drug in Dry Eye. Beating Xiidra already and Restasis in many markets. Sorry you are a Hater.
Systane is OTC—-sorry, doesn’t do what Miebo does. We even have studies to show Systane Ultra doesn’t do jack sh*t for evaporation.I hate alcon, but they have the number one drug in dry eye. It's called Systane. Sorry, your drug is junk.
Systane relieves dry eyes, period. miebo, like systane, provides symptomatic relief, period. The mode of action is irrelevent, period. The difference is that systane comes at a fraction of the cost. You said number one drug. Systane is the number one drug for dry eye relief, period. It's a benefit that systane is OTC. You and bausch and lomb lose and will continue to be losers for the foreseeable future.Systane is OTC—-sorry, doesn’t do what Miebo does. We even have studies to show Systane Ultra doesn’t do jack sh*t for evaporation.
Alcon loses AGAIN.
*irrelevant*Systane relieves dry eyes, period. miebo, like systane, provides symptomatic relief, period. The mode of action is irrelevent, period. The difference is that systane comes at a fraction of the cost. You said number one drug. Systane is the number one drug for dry eye relief, period. It's a benefit that systane is OTC. You and bausch and lomb lose and will continue to be losers for the foreseeable future.
Even a retina specialist can understand through logical reasoning that bausch and lomb is a big huge stinky pile of shit. Unfortunately for them, their egos' are tied to your foul excrement.YTD bausch and lomb's stock is down over 11%. Since May of 2022, bausch and lomb's stock is down over 20%. Sounds like miebo isn't the answer. That said, good job, team!
In comparison, alcon's stock is up over 10%. Over the past 5 years, alcon's stock is up over 55%.
Who is the loser? The correct answer is you and bausch and lomb.
No truer words have ever been spoken. This is a house of cards, for people who can’t get better jobs. It’s a freaking joke!I get my Miebo OTC from Germany. $23.00 Good luck convincing me to pay $700 for it. The only stupid people are the ones buying this and the ones selling it. Go get a real job with a real company.
It's a hyped up artificial tear! And they try to spin it like it's not so they can continue to price gouge.I get my Miebo OTC from Germany. $23.00 Good luck convincing me to pay $700 for it. The only stupid people are the ones buying this and the ones selling it. Go get a real job with a real company.
An artificial tear is the same as Systane? It provides relief for 3-5 mins. Miebo not only stays on the eye. It also heals the ocular surface. So BIG DIFFERENCESystane relieves dry eyes, period. miebo, like systane, provides symptomatic relief, period. The mode of action is irrelevent, period. The difference is that systane comes at a fraction of the cost. You said number one drug. Systane is the number one drug for dry eye relief, period. It's a benefit that systane is OTC. You and bausch and lomb lose and will continue to be losers for the foreseeable future.
Evotears…. Half the price for the same thingAn artificial tear is the same as Systane? It provides relief for 3-5 mins. Miebo not only stays on the eye. It also heals the ocular surface. So BIG DIFFERENCE
Are you sure they aren’t just calling the doctors and sending a form to them for samples?There is an Eversana contract team carrying Miebo, calling on prescribers. Why arent we working with them. We may have different prescribers but we are in the same territories.
No, there are 30 or 40 in select territories in the fieldAre you sure they aren’t just calling the doctors and sending a form to them for samples?
They tried that with Areds reps and that failed miserably.
Unique MOA, but they fucked up that launch. Do their reps even work? I never see them.What's an honest assessment of Tyrvaya?
Seems a failure of a launch, but I am interviewing for one of their many NY openings. Is the product that bad, or just the reps selling it? I think I could easily be average and be a star over there.
Very little insurance coverage and bad adverse event profile tooUnique MOA, but they fucked up that launch. Do their reps even work? I never see them.